Tariquidar
Jump to navigation
Jump to search
This article relies largely or entirely on a single source. (August 2014) |
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C38H38N4O6 |
Molar mass | 646.744 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Tariquidar (INN/USAN) is a P-glycoprotein inhibitor[1] undergoing research as an adjuvant against multidrug resistance in cancer.
References
- ^ Robey RW, Shukla S, Finley EM, Oldham RK, Barnett D, Ambudkar SV, Fojo T, Bates SE (March 2008). "Inhibition of P-glycoprotein (ABCB1)- and multidrug resistance-associated protein 1 (ABCC1)-mediated transport by the orally administered inhibitor, CBT-1((R))". Biochemical Pharmacology. 75 (6): 1302–12. doi:10.1016/j.bcp.2007.12.001. PMC 2346578. PMID 18234154.
Categories:
- Articles with short description
- Short description matches Wikidata
- Articles needing additional references from August 2014
- All articles needing additional references
- Drugs not assigned an ATC code
- Articles with changed ChemSpider identifier
- Articles with changed EBI identifier
- Articles with changed InChI identifier
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Drugboxes which contain changes to watched fields
- Experimental cancer drugs
- Quinolines
- Benzanilides
- Norsalsolinol ethers
- Nicotinamides
- All stub articles
- Antineoplastic and immunomodulating drug stubs